InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: dr_lowenstein post# 44011

Tuesday, 04/10/2018 2:18:43 PM

Tuesday, April 10, 2018 2:18:43 PM

Post# of 48316
trials take a long time and when Oncosec changed the protocol of the first Merck combo trial to include non-responders to anti-pd1....they did so knowing that it would be the fastest route to an approval which will likely be within 1 year now. That means that with a positive review from the FDA...Oncosec is likely going to get buyout interest. This weekend we may hear news about Bristol Myers interest in TNBC combo with Oncosec also.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News